|
General Information
|
|
|
Product
|
E2F2 Peptide
|
|
Description
|
Antigenic Blocking Peptide Transcription Factor E2F2 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide
|
|
Accession #
|
NCBI: NP_808401.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P56931
|
|
Overview
|
Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication
|
|
Molecular Function
|
core promoter binding; sequence-specific DNA binding transcription factor activity.
|
|
Subcellular Location
|
Nucleus
|
|
Expression
|
developing epidermis and intestinal epithelium;thymus; liver;nervous system
|
|
Structure
|
Component of the DRTF1/E2F transcription factor complex. Forms heterodimers with DP family members
|
|
Alternative Nomenclature
|
dE2F2 antibody
E2F transcription factor 2 antibody
E2F transcription factor 2 antibody
E2F-2 antibody
E2F2 antibody
E2F2_HUMAN antibody
Transcription factor E2F2 antibody
|
| |
|
E2F2 Antibody
E2F2 Antibody FITC
E2F2 Antibody BIOTIN
E2F2 Positive Control
